ClinicalTrials.Veeva

Menu

Efficacy and Safety of Extract of Gelidium Elegans

Yonsei University logo

Yonsei University

Status

Completed

Conditions

Obesity

Treatments

Dietary Supplement: Placebo
Dietary Supplement: Exract of Gelidium elegans

Study type

Interventional

Funder types

Other

Identifiers

NCT03842774
4-2017-0860

Details and patient eligibility

About

Extract of Gelidium elegans inhibits lipid differentiation, accumulation, and synthesis in vitro and in vivo. It has also anti-obesity effect by inhibiting weight gain and decreasing body fat. In a preliminary study of obese adults aged 20 years or older, the extracts of Gelidium elegans showed a tendency to decrease in body fat and visceral fat, and to increase lean body mass. Based on these results, we tried to confirm the effect of body weight and body fat reduction of Gelidium elegans extract in overweight and obese people.

Enrollment

94 patients

Sex

All

Ages

19 to 50 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

    1. Between the ages of 19 and 50
    1. BMI is at or greater than 23 and less than 30 kg/m^2

Exclusion criteria

    1. uncontrolled hypertension
    1. uncontrolled diabetes
    1. current serious cerebrovascular and cardiovascular disease

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

94 participants in 2 patient groups, including a placebo group

Test group
Experimental group
Description:
taken 3 tablets of Gelidium elegans extract (1000 mg/day) once a day for 12 weeks
Treatment:
Dietary Supplement: Exract of Gelidium elegans
Control group
Placebo Comparator group
Description:
taken 3 tablets of placebo once a day for 12 weeks
Treatment:
Dietary Supplement: Placebo

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems